X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (958) 958
normal karyotype (658) 658
index medicus (632) 632
female (626) 626
male (491) 491
adult (487) 487
hematology (384) 384
leukemia, myeloid, acute - genetics (374) 374
middle aged (355) 355
acute myelogenous leukemia (321) 321
oncology (321) 321
prognosis (318) 318
mutation (288) 288
aged (253) 253
karyotyping (246) 246
pregnancy (245) 245
adolescent (223) 223
obstetrics & gynecology (219) 219
acute myeloid leukemia (216) 216
nuclear proteins - genetics (202) 202
normal cytogenetics (194) 194
aml (187) 187
genetics & heredity (187) 187
young adult (167) 167
acute myeloid-leukemia (164) 164
internal tandem duplication (144) 144
cancer (142) 142
fms-like tyrosine kinase 3 - genetics (137) 137
aged, 80 and over (135) 135
favorable prognosis (134) 134
leukemia, myeloid, acute - mortality (133) 133
leukemia, myeloid, acute - diagnosis (121) 121
gene-mutations (117) 117
chromosome aberrations (112) 112
leukemia (107) 107
leukemia, myeloid, acute - pathology (107) 107
research (104) 104
cytogenetics (101) 101
mutations (101) 101
nuchal translucency (101) 101
child (100) 100
analysis (98) 98
genetic aspects (97) 97
group-b (91) 91
chromosomally normal fetuses (90) 90
retrospective studies (89) 89
treatment outcome (89) 89
prognostic-significance (87) 87
leukemia, myeloid, acute - metabolism (86) 86
younger adults (86) 86
gene expression (84) 84
gene expression profiling (82) 82
infant, newborn (81) 81
abnormalities (80) 80
karyotype (80) 80
leukemia, myeloid, acute - drug therapy (80) 80
risk factors (80) 80
gene mutations (79) 79
hemic and lymphatic diseases (79) 79
survival analysis (78) 78
expression (76) 76
adult patients (75) 75
ultrasonography, prenatal (75) 75
minimal residual disease (74) 74
diagnosis (73) 73
disease-free survival (73) 73
nucleophosmin (73) 73
aneuploidy (72) 72
chromosomes (71) 71
in situ hybridization, fluorescence (71) 71
leukemia, myeloid, acute - therapy (70) 70
pregnancy outcome (70) 70
gestation (69) 69
pregnancy trimester, first (69) 69
phenotype (68) 68
cell biology (67) 67
cytoplasmic nucleophosmin (66) 66
dna mutational analysis (64) 64
fetuses (64) 64
nuchal translucency measurement (64) 64
acute disease (63) 63
thickness (63) 63
npm1 (62) 62
radiology, nuclear medicine & medical imaging (62) 62
child, preschool (61) 61
npm1 mutations (61) 61
abridged index medicus (60) 60
animals (60) 60
neoplasm proteins - genetics (60) 60
infant (59) 59
gene (58) 58
antineoplastic combined chemotherapy protocols - therapeutic use (57) 57
leukemia, myeloid - genetics (57) 57
remission induction (55) 55
flt3 (54) 54
health aspects (54) 54
in-situ hybridization (54) 54
chemotherapy (53) 53
genes (53) 53
pediatrics (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1166) 1166
German (12) 12
French (7) 7
Korean (7) 7
Polish (6) 6
Spanish (4) 4
Russian (3) 3
Czech (2) 2
Portuguese (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2014, Volume 89, Issue 3, pp. 249 - 255
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2013, Volume 88, Issue 12, pp. 1001 - 1006
De novo acute myeloid leukemia with normal karyotype (NK‐AML) comprises a large group of patients with no common cytogenetic alterations and with a large... 
PROGNOSTIC IMPLICATIONS | INTERNAL TANDEM DUPLICATION | Nothing to report | IN-VITRO | DEOXYCYTIDINE KINASE | C SENSITIVITY | ACUTE MYELOGENOUS LEUKEMIA | INTRACELLULAR CONCENTRATIONS | NORMAL CYTOGENETICS | ACUTE MYELOID-LEUKEMIA | FLT3 MUTATIONS | HEMATOLOGY | 5'-Nucleotidase - genetics | Prognosis | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Middle Aged | Male | Tandem Repeat Sequences | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Cytarabine - pharmacokinetics | DNA Methylation | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Idarubicin - administration & dosage | Leukemia, Myeloid, Acute - surgery | Deoxycytidine Kinase - genetics | Neoplasm Proteins - genetics | Daunorubicin - administration & dosage | Topoisomerase I Inhibitors - pharmacokinetics | Cytidine Deaminase - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Combined Modality Therapy | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Aged | Inactivation, Metabolic - genetics | Polymorphism, Single Nucleotide | Karyotype | Leukemia, Myeloid, Acute - genetics | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 1, pp. 61 - 70
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2012, Volume 91, Issue 1, pp. 9 - 18
Journal Article